| The somatic genomic landscape of chromophobe renal cell carcinoma CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ... Cancer cell 26 (3), 319-330, 2014 | 728 | 2014 |
| The transcriptional landscape and mutational profile of lung adenocarcinoma JS Seo, YS Ju, WC Lee, JY Shin, JK Lee, T Bleazard, J Lee, YJ Jung, ... Genome research 22 (11), 2109-2119, 2012 | 614 | 2012 |
| Human glioblastoma arises from subventricular zone cells with low-level driver mutations JH Lee, JE Lee, JY Kahng, SH Kim, JS Park, SJ Yoon, JY Um, WK Kim, ... Nature 560 (7717), 243-247, 2018 | 535 | 2018 |
| Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020 | 487 | 2020 |
| Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature genetics 52 (3), 331-341, 2020 | 409 | 2020 |
| Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas JK Lee, J Lee, S Kim, S Kim, J Youk, S Park, Y An, B Keam, DW Kim, ... Journal of clinical oncology 35 (26), 3065-3074, 2017 | 341 | 2017 |
| Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation MH Kim, J Kim, H Hong, SH Lee, JK Lee, E Jung, J Kim The EMBO journal 35 (5), 462-478, 2016 | 212 | 2016 |
| Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial SH Lee, JK Lee, MJ Ahn, DW Kim, JM Sun, B Keam, TM Kim, DS Heo, ... Annals of Oncology 28 (2), 292-297, 2017 | 197 | 2017 |
| Detecting the mutational signature of homologous recombination deficiency in clinical samples DC Gulhan, JJK Lee, GEM Melloni, I Cortes-Ciriano, PJ Park Nature genetics 51 (5), 912-919, 2019 | 181 | 2019 |
| Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking J Kim, H Jo, H Hong, MH Kim, JM Kim, JK Lee, WD Heo, J Kim Nature communications 6 (1), 6781, 2015 | 174 | 2015 |
| Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non–small cell lung cancer harboring wild-type epidermal growth factor receptor: a … JK Lee, S Hahn, DW Kim, KJ Suh, B Keam, TM Kim, SH Lee, DS Heo Jama 311 (14), 1430-1437, 2014 | 164 | 2014 |
| Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer KC Akdemir, VT Le, S Chandran, Y Li, RG Verhaak, R Beroukhim, ... Nature genetics 52 (3), 294-305, 2020 | 159 | 2020 |
| Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients HS Park, JK Lee, DW Kim, K Kulig, TM Kim, SH Lee, YK Jeon, DH Chung, ... Lung cancer 77 (2), 288-292, 2012 | 140 | 2012 |
| Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR … JK Lee, JY Shin, S Kim, S Lee, C Park, JY Kim, Y Koh, B Keam, HS Min, ... Annals of oncology 24 (8), 2080-2087, 2013 | 138 | 2013 |
| Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma JJK Lee, S Park, H Park, S Kim, J Lee, J Lee, J Youk, K Yi, Y An, IK Park, ... Cell 177 (7), 1842-1857. e21, 2019 | 137 | 2019 |
| Mechanisms and consequences of cancer genome instability: lessons from genome sequencing studies JK Lee, YL Choi, M Kwon, PJ Park Annual Review of Pathology: Mechanisms of Disease 11, 283-312, 2016 | 126 | 2016 |
| Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation JK Lee, TM Kim, Y Koh, SH Lee, DW Kim, YK Jeon, DH Chung, SC Yang, ... Lung cancer 77 (2), 460-463, 2012 | 109 | 2012 |
| A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling DHT Nguyen, E Lee, S Alimperti, RJ Norgard, A Wong, JJK Lee, ... Science advances 5 (8), eaav6789, 2019 | 103 | 2019 |
| Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT H Choi, JC Paeng, DW Kim, JK Lee, CM Park, KW Kang, JK Chung, ... Lung Cancer 79 (3), 242-247, 2013 | 73 | 2013 |
| Comparative analyses of overall survival in patients with anaplastic lymphoma kinase‐positive and matched wild‐type advanced nonsmall cell lung cancer JK Lee, HS Park, DW Kim, K Kulig, TM Kim, SH Lee, YK Jeon, DH Chung, ... Cancer 118 (14), 3579-3586, 2012 | 68 | 2012 |
